Home › Diabetes › Tennessee › Memphis
Diabetes clinical trials in Memphis, TN
5 studies for Diabetes are looking for participants at sites in and around Memphis (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
RecruitingPhase 2/3
- Lt. Col. Luke Weathers, Jr. VA Medical Center, Memphis
CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)
RecruitingPhase 1/2
- Le Bonhuer Children's, Memphis
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
RecruitingPhase 3
- Kailea Clinical Site, Memphis
Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer
RecruitingObservational study
- Methodist LeBonheur Healthcare, Memphis
Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence
Recruiting
- University of Tennessee Health Science Center/Regional One Health, Memphis
About Diabetes
Diabetes is a chronic health condition in which your blood glucose levels are too high. There is no cure, but diet, exercise, medications, and weight control can help.
More about Diabetes on MedlinePlus
Diabetes trials in other cities
- Boston, MA23 studies
- New York City, NY17 studies
- Houston, TX16 studies
- Chicago, IL15 studies
- Durham, NC14 studies
- Aurora, CO14 studies
- Baltimore, MD13 studies
- Philadelphia, PA12 studies
- Los Angeles, CA10 studies
- Washington, DC10 studies
- San Diego, CA10 studies
- Indianapolis, IN10 studies
Other studies in Memphis
- Cancer (all types)31 studies
- Non-Small Cell Lung Cancer23 studies
- Breast Cancer22 studies
- Lung Cancer18 studies
- Sickle Cell Disease18 studies
- Acute Lymphoblastic Leukemia16 studies
- Acute Myeloid Leukemia15 studies
- Heart Failure13 studies
- Colorectal Cancer11 studies
- Soft Tissue Sarcoma11 studies
- Melanoma11 studies
- Prostate Cancer11 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.